Patent Assignment
Reel/Frame 064817/0471
Assignment of Assignor's Interest
Recorded: 2023-09-06
Pages: 4
Assignor
SILVERGATE PHARMACEUTICALS, INC.
Executed: 2023-09-06
Assignee
AZURITY PHARMACEUTICALS, INC.
8 CABOT ROAD, SUITE 2000, WOBURN, MASSACHUSETTS, 01801
Covered Properties
(12)
Lisinopril Formulations
Patent:
9,463,183 →
Application:
14/934,752 →
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Application:
16/564,904 →
Publication:
US 2020/0206298
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Lisinopril Formulations
Application:
62/249,011 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 3, 2015
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 037042/0682 →
Assignment of Assignor's Interest
Nov 6, 2015
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 037066/0263 →
Assignment of Assignor's Interest
Sep 16, 2016
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 040066/0323 →
Assignment of Assignor's Interest
Apr 19, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 042097/0015 →
Assignment of Assignor's Interest
Nov 10, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044090/0445 →
Assignment of Assignor's Interest
Sep 5, 2018
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047479/0828 →
Security Interest
Dec 19, 2018
From: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
To: WHITE OAK HEALTHCARE FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 047815/0615 →
Assignment of Assignor's Interest
Mar 7, 2019
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 048536/0610 →
Release of Security Interest
May 17, 2019
From: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
To: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 049211/0188 →
Security Interest
May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Assignment of Assignor's Interest
Sep 9, 2019
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 050320/0949 →
Assignment of Assignor's Interest
Dec 31, 2020
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 055759/0725 →
Security Interest
Apr 16, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055938/0895 →
Assignment of Assignor's Interest
Jul 28, 2021
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057012/0739 →
Release of Security Interest
Aug 23, 2021
From: GOLDMAN SACHS BANK USA
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057253/0348 →
Release of Security Interest
Sep 20, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057531/0556 →
Security Interest
Sep 20, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057532/0550 →
Assignment of Assignor's Interest
Jan 11, 2022
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 058694/0289 →
Assignment of Assignor's Interest
Sep 13, 2023
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 064885/0955 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents
Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →